Molecular Mechanisms of Lipid Droplet Biogenesis

脂滴生物发生的分子机制

基本信息

批准号：
9178664
负责人：
JAMES A OLZMANN
金额：
$ 29.38万
依托单位：
UNIVERSITY OF CALIFORNIA BERKELEY
依托单位国家：
美国
项目类别：
财政年份：
2014
资助国家：
美国
起止时间：
2014-12-01 至 2019-11-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9178664
关键词：
Aging Area Biochemical Biogenesis Biology Biotinylation Cardiovascular Diseases Cells Cellular biology Collaborations Communities Critical Pathways Cytoplasm Data Development Diabetes Mellitus Disease Dissection Endoplasmic Reticulum Epidemic Etiology Fatty Liver Fatty acid glycerol esters Fluorescence Microscopy Functional disorder Future Genes Genetic Genomic approach Goals Growth Human Label Libraries Link Lipid Mobilization Lipids Liver diseases Malignant Neoplasms Maps Mass Spectrum Analysis Measures Mediating Membrane Metabolic Diseases Metabolic Pathway Methods Molecular Nutrient Obesity Organelles Pathogenesis Pathway interactions Peripheral Phospholipids Prevalence Production Proteins Proteome Proteomics RNA interference screen Recruitment Activity Regulation Regulatory Pathway Research Role Site Source System Technology Therapeutic Intervention Triglycerides Ubiquitin Ubiquitination United States Yeasts base cell type density experience functional genomics genetic regulatory protein human disease insight interest lipid metabolism membrane biogenesis metabolomics monolayer new therapeutic target novel novel therapeutics protein complex protein protein interaction public health relevance screening small hairpin RNA small molecule inhibitor stem time use treatment strategy whole genome

项目摘要

DESCRIPTION (provided by applicant): The prevalence of metabolic diseases has reached epidemic proportions in the United States. In cells, nutrients are stored as triacylglycerol (i.e. at) in lipid droplets (LDs), a conserved endoplasmic reticulum-derived organelle that is consists of a neutral lipid core encircled by a phospholipid monolayer decorated with regulatory proteins. Storage of triacylglycerol in LDs is not only critical for energy production and as a source of membrane precursors, but is central to the pathogenesis of metabolic diseases, such as obesity, diabetes, and cardiovascular disease, and has been linked to aging and cancer. For years LDs were thought of as inert cytoplasmic fat globules and there was little interest among the scientific research community. The recognition that LDs are integrally involved in the etiology of multiple diseases and that LDs are extremely dynamic organelles has paved the way for a burgeoning area of research with the potential to make a significant impact on future treatment strategies for metabolic diseases. LDs fundamentally function as hubs of cellular lipid metabolism, and it is essential that we understand the mechanisms that regulate LD biogenesis and function. Therefore, my proposed research will specifically: 1) Exploit advanced functional genomic strategies to generate a high-density epistatic map of all genes required for LD biogenesis in human cells, 2) Use metabolomics technologies to define the functional impact of ER-LD ubiquitination machinery in LD biogenesis and lipid metabolism, and 3) Utilize proximity labeling proteomic methods to define ER subdomains specialized for LD biogenesis and to determine the temporal dynamics of LD proteome maturation. Integration of these complementary studies will break new ground in cell biology and metabolic disease treatment strategies by advancing our understanding of the mechanisms underlying LD biogenesis and the molecular basis of LD dysfunction in human diseases.

描述（由申请人提供）：代谢疾病的患病率在美国已达到流行病的程度。在细胞中，营养物质以三酰甘油（即at）的形式储存在脂滴（LD）中，脂滴是一种保守的内质网衍生细胞器，由被装饰有调节蛋白的磷脂单层包围的中性脂质核心组成。 LD 中三酰甘油的储存不仅对于能量产生和作为膜前体的来源至关重要，而且对于肥胖、糖尿病和心血管疾病等代谢疾病的发病机制至关重要，并且与衰老和癌症有关。多年来，LD 被认为是惰性细胞质脂肪球，科学研究界对此兴趣不大。 LDs 与多种疾病的病因学密切相关，并且 LDs 是极其动态的细胞器，这一认识为新兴的研究领域铺平了道路，有可能对未来代谢疾病的治疗策略产生重大影响。 LD 从根本上来说是细胞脂质代谢的枢纽，我们了解调节 LD 生物发生和功能的机制至关重要。因此，我提出的研究将具体：1）利用先进的功能基因组策略来生成人类细胞中 LD 生物发生所需的所有基因的高密度上位图谱，2）使用代谢组学技术来定义 ER-LD 泛素化机制的功能影响LD 生物发生和脂质代谢，3) 利用邻近标记蛋白质组学方法来定义专门用于 LD 生物发生的 ER 子域，并确定 LD 蛋白质组成熟的时间动态。这些互补研究的整合将促进我们对 LD 生物发生机制和人类疾病中 LD 功能障碍的分子基础的理解，从而在细胞生物学和代谢疾病治疗策略方面开辟新天地。